News
Sports
Life
Opinion
Business
Advertise
Obituaries
eNewspaper
Legals
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
NewsOK Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Acorda Therapeutics, Inc.
Acorda Therapeutics to Present at H.C. Wainwright 24th Annual Global Investment Conference
September 08, 2022
From
Acorda Therapeutics, Inc.
Via
Business Wire
Tickers
ACOR
Acorda Therapeutics Enters into License Agreement with Asieris Pharmaceuticals
August 29, 2022
From
Acorda Therapeutics, Inc.
Via
Business Wire
Tickers
ACOR
Acorda Therapeutics Announces Resignation of Chief Operating Officer
August 19, 2022
From
Acorda Therapeutics, Inc.
Via
Business Wire
Tickers
ACOR
Acorda Therapeutics Reports Second Quarter 2022 Financial Results
August 04, 2022
From
Acorda Therapeutics, Inc.
Via
Business Wire
Tickers
ACOR
Acorda Second Quarter 2022 Update: Webcast/Conference Call Scheduled for August 4, 2022
July 28, 2022
From
Acorda Therapeutics, Inc.
Via
Business Wire
Tickers
ACOR
Esteve Launches INBRIJA® in Germany
June 16, 2022
From
Acorda Therapeutics, Inc.
Via
Business Wire
Tickers
ACOR
Acorda Therapeutics Reports First Quarter 2022 Financial Results
May 11, 2022
From
Acorda Therapeutics, Inc.
Via
Business Wire
Tickers
ACOR
Acorda Therapeutics and Biopas Laboratories Announce Agreement to Commercialize INBRIJA® in Latin America
May 11, 2022
From
Acorda Therapeutics, Inc.
Via
Business Wire
Tickers
ACOR
Acorda First Quarter 2022 Update: Webcast/Conference Call Scheduled for May 11, 2022
May 04, 2022
From
Acorda Therapeutics, Inc.
Via
Business Wire
Tickers
ACOR
Acorda Fourth Quarter/Year End 2021 Update: Webcast/Conference Call Scheduled for March 9, 2022
February 24, 2022
From
Acorda Therapeutics, Inc.
Via
Business Wire
Tickers
ACOR
Acorda Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
January 04, 2022
From
Acorda Therapeutics, Inc.
Via
Business Wire
Tickers
ACOR
John Varian Joins Acorda Therapeutics Board of Directors
January 03, 2022
From
Acorda Therapeutics, Inc.
Via
Business Wire
Tickers
ACOR
Acorda Therapeutics Announces Agreement to Commercialize INBRIJA® in Germany
November 09, 2021
From
Acorda Therapeutics, Inc.
Via
Business Wire
Tickers
ACOR
Acorda Therapeutics Reports Third Quarter 2021 Financial Results, Additions to Leadership Team
November 09, 2021
From
Acorda Therapeutics, Inc.
Via
Business Wire
Tickers
ACOR
Acorda Third Quarter 2021 Update: Webcast Scheduled for November 9, 2021
November 02, 2021
From
Acorda Therapeutics, Inc.
Via
Business Wire
Tickers
ACOR
Acorda Therapeutics Announces Corporate Restructuring, Management Changes
September 09, 2021
From
Acorda Therapeutics, Inc.
Via
Business Wire
Tickers
ACOR
Acorda Therapeutics Reports Second Quarter 2021 Financial Results
August 05, 2021
From
Acorda Therapeutics, Inc.
Via
Business Wire
Tickers
ACOR
Acorda Second Quarter 2021 Update: Webcast/Conference Call Scheduled for August 5, 2021
July 30, 2021
From
Acorda Therapeutics, Inc.
Via
Business Wire
Tickers
ACOR
Acorda Therapeutics Announces Agreement to Commercialize INBRIJA® in Spain
July 22, 2021
From
Acorda Therapeutics, Inc.
Via
Business Wire
Tickers
ACOR
Acorda Therapeutics Announces Repayment of Convertible Senior Notes
June 16, 2021
From
Acorda Therapeutics, Inc.
Via
Business Wire
Tickers
ACOR
Acorda Therapeutics Reports First Quarter 2021 Financial Results
May 06, 2021
From
Acorda Therapeutics, Inc.
Via
Business Wire
Tickers
ACOR
Acorda Therapeutics First Quarter 2021 Update: Webcast/Conference Call Scheduled for May 6, 2021
April 29, 2021
From
Acorda Therapeutics, Inc.
Via
Business Wire
Tickers
ACOR
Celebrity Chef Zarela Martinez Partners with Acorda Therapeutics on the launch of “A Taste for Life with Zarela℠”
April 12, 2021
From
Acorda Therapeutics, Inc.
Via
Business Wire
Tickers
ACOR
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.